ProPhase Labs to Release Fourth Quarter Results on Tuesday, March 6th

(firmenpresse) - DOYLESTOWN, PA -- (Marketwire) -- 02/29/12 -- ProPhase Labs (NASDAQ: PRPH) announced today that financial results for the fourth quarter and the year ended December 31, 2011, will be released before the market opens on Tuesday, March 6, 2012.



ProPhase Labs is a diversified natural health medical science company. It is a leading marketer and manufacturer of the Cold-EEZE® family of lozenges clinically proven to significantly reduce the severity and duration of the common cold. Cold-EEZE customers include leading national retailers, chain food, drug and mass merchandise stores, wholesalers and distributors, as well as independent pharmacies. ProPhase Labs has several wholly owned subsidiaries including a manufacturing unit, which consists of an FDA registered facility to manufacture Cold-EEZE lozenges and fulfill other contract manufacturing opportunities. ProPhase also owns 50% of Phusion Laboratories LLC ("Phusion"). Phusion licenses a revolutionary proprietary technology that has the potential to improve the delivery and/or efficacy of many active ingredients or compounds. Phusion will formulate and test products to exploit market opportunities within ProPhase's robust OTC distribution channels. For more information visit us at .



Press Only Contact:
Jenny Miranda
5W Public Relations
Tel: (212) 584-4295


Investor Relations:
Ted Karkus
Chairman of the Board, CEO
(215) 345-0919 x0

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 29.02.2012 - 22:30 Uhr
Sprache: Deutsch
News-ID 120339
Anzahl Zeichen: 0

contact information:
Town:

DOYLESTOWN, PA

Kategorie:

Health & Nutrition

Diese Pressemitteilung wurde bisher 270 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"ProPhase Labs to Release Fourth Quarter Results on Tuesday, March 6th"
steht unter der journalistisch-redaktionellen Verantwortung von

ProPhase Labs (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

ProPhase Labs Reports Financial Results for the Three and Nine Months Ended Sept ...

DOYLESTOWN, PA -- (Marketwired) -- 11/12/15 -- (NASDAQ: PRPH) () today reported its net sales were $4.4 million for the three months ended September 30, 2015, as compared to net sales of $5.1 million for the three months ended September 30, 2014. T ...

ProPhase Labs Reports Financial Results for the Three and Six Months Ended June ...

DOYLESTOWN, PA -- (Marketwired) -- 08/12/15 -- (NASDAQ: PRPH) () today reported its net sales were $2.2 million for the three months ended June 30, 2015, as compared to net sales of $1.8 million for the three months ended June 30, 2014. The Company ...

ProPhase Establishes 3.2 Million Share Equity Line ...

DOYLESTOWN, PA -- (Marketwired) -- 08/05/15 -- ProPhase Labs, Inc. (NASDAQ: PRPH) () announced today that as of July 30, 2015, it entered into an Investment Agreement (the "Investment Agreement") with Dutchess Opportunity Fund, II, LP, a D ...

Alle Meldungen von ProPhase Labs